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Abstract The catalytic effect of buffers (phosphate, acetate, borate, carbonate) on
the degradation of doripenem in aqueous solutions was studied at 313 K in the pH
range 0.82–11.56 (l = 0.50 mol L-1) by an HPLC-UV method developed for
kinetic studies of doripenem. It was observed that general acid–base catalysis
occurred in all buffers and so catalytic rate constants were calculated. Specific acid–
base catalysis of doripenem involved degradation of protonated molecules and
zwitter ions of doripenem catalyzed by hydrogen ions, spontaneous degradation of
zwitter ions under the influence of water and degradation of zwitter ions and
monoanions catalyzed by hydroxide ions.
Keywords Doripenem  Catalytic effect of buffers  Catalytic rate constants 
pH-rate profile
Introduction
Doripenem (S-4661) is a new parenteral carbapenem (Fig. 1). Doripenem, similarly
to meropenem, ertapenem and biapenem, contains a 1-b-methyl group that prevents
degradation caused by renal dehydropeptidase I and therefore does not need to be
protected with an inhibitor of this enzyme [1, 2]. Doripenem has a broad spectrum
of antimicrobial activity, against both Gram-postitive and Gram-negative bacteria,
including Pseudomonas aeruginosa [3–5].
Carbapenems are susceptible to degradation during storage and after preparation
of parenteral solutions [6–11]. The catalytic effect of citrate, phosphate, acetate,
borate and carbonate buffers on the degradation of imipenem has been studied [12].
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The components of carbonate buffer do not demonstrate a catalytic effect on the
degradation of ertapenem but it was observed that catalysis occurs in the presence
of acetate, phosphate and borate buffers [13]. Specific acid–base catalysis of
carbapenems involves: (a) hydrolysis of imipenem, meropenem and ertapenem
catalyzed by hydrogen ion; (b) spontaneous hydrolysis independent of the charge of
imipenem and meropenem or dependent on zwitter ions and dianions of ertapenem
under the influence of water and (c) hydrolysis of imipenem, meropenem and
ertapenem catalyzed by hydroxide ions [13–15].
The aim of this study was to analyze general and specific acid–base hydrolysis of
doripenem in the pH range 0.82–11.56, at 313 K. To determine the reaction rate
constants under the influence of buffers, an isocratic HPLC-UV method was used.
Experimental
Material and reagents
Doripenem for injection, DORIBAXTM (Janssen-Cilag International NV), is a white
to slightly yellowish sterile crystalline powder. Injection vials contain 500 mg of
doripenem monohydrate as an anhydrous basis. The pH of the infusion solution is
between 4.5 and 5.5. DORIBAXTM is formulated without any excipients.
Theophylline was used as an internal standard. All other chemicals and solvents
were obtained from Merck KGaA (Germany) and were of analytical or high-
performance liquid chromatographic grade. High-quality pure water was prepared
by using the Millipore purification system (Millipore, Molsheim, France, model Exil
SA 67120).
Chromatographic conditions
Chromatographic separation and quantitative determination were performed by using
a high performance liquid chromatograph containing a Shimadzu pump, model LC-
6A, a UV-VIS detector SPD-6AV (Shimadzu), a Rheodyne 7120 with a 50 lL loop.
As the stationary phase, a Lichrospher RP-18, 5 lm particle size, 250 mm 9 4 mm
(Merck, Darmstadt, Germany) was used. The mobile phase consisted of 4 volumes of
acetonitrile and 96 volumes of ammonium acetate, 12 mmol L-1. The flow rate of the
mobile phase was 1.2 mL min-1 and the wavelength of the UV-vis detector was set
at 298 nm. The HPLC method has been evaluated and validated for the determination











Fig. 1 Chemical structure of
doripenem
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buffers on the stability of doripenem, the selectivity was examined for degraded
samples in buffers.
Kinetic procedures
The degradation of doripenem in aqueous solutions was studied at 313 K in
hydrochloric acid (pH 0.82–2.05), phosphate (pH 2.10–3.38 and 6.36–7.77), acetate
(pH 4.23–6.04), borate (pH 7.95–10.49) and carbonate (11.27–11.56) buffers. The
pH values of the solutions and those of the buffer standards used to calibrate the
pH-meter were measured at reaction temperatures. The pH values of the reaction
solutions in HCl were calculated from the equation pH = -log c HCl [HCl] [17].
The ionic strength of all solutions was adjusted to 0.5 mol L-1 with a solution of
sodium chloride (4 mol L-1).
Degradation was initiated by dissolving an accurately weighed 5.0 mg of
DORIBAXTM in 25 mL of the solution equilibrated to 313 K in stopped flasks. At
specified times, samples of the reaction solutions (1.0 mL) were collected and
instantly cooled with a mixture of ice and water, neutralized with 0.8 ml of NaOH
solutions of suitable concentrations and assayed. To each sample, 1.0 mL of the
internal standard (theophylline 0.1 mg mL-1) was added.
Results and discussion
The HPLC method with UV detection used in this study has been found suitable for
the determination of doripenem and biapenem under the stress conditions of
hydrolysis (acid and base), oxidation, photolysis and thermal degradation [16]. The
literature reports the influence of solution pH, temperature and concentration of
meropenem, ertapenem and biapenem on the formation of their degradation of
products [6, 7, 18]. In this study, the selectivity of this method for the determination
of doripenem in the presence of degradation products formed in buffers was
confirmed. In the chromatogram, the symmetrical peak of doripenem (tR =
5.8 min) was clearly separated from the peak the of degradation products which
formed in the pH range 0.86–11.56 (Fig. 2).
The degradation of doripenem in DORIBAXTM is a pseudo first-order reaction
described by the following equation:
lnðPD=PISÞ ¼ lnðPD=PISÞ0  kobst
PD and PIS are the areas of the peaks of doripenem and the internal standard, at time
t = 0 and t, respectively. The semi-logarithmic plots ln (PD/PIS) = f(t) were linear
and their slopes were equal to the rate constants of the reactions with the negative
sign (-kobs).
At a constant pH, ionic strength (0.50 mol L-1) and temperature, the rate
constant kobs for the degradation of doripenem increased linearly as the total
concentrations of the acetate, phosphate, borate and carbonate buffers increased
(Fig. 3). The observed rate constant is a sum of several catalytic rate constants
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catalyzed by the buffer components and the rate constant at zero buffer
concentration. Under the conditions of general acid–base catalysis, kobs was
calculated from the following equation:
Fig. 2 HPLC chromatograms
of: solution of doripenem at t = 0
(c = 7.50 9 10-2 mg/mL);
solution of doripenem and its
degradation products in borate
buffer (pH 8.10) after incubation
7.5 min at 313 K (D doripenem,







































Fig. 3 Plots of kobs = f(BT) for the degradation of doripenem in acetate (pH 4.23–6.04) and in borate
buffers (pH 7.95–10.49) at 313 K
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kobs ¼ kpH þ kB½BT ð1Þ
[BT] is the total buffer concentration, kpH the rate constant at zero buffer
concentration, kB is the catalytic effect of the buffer components.
The catalytic effect of the acetate buffer was investigated at pH 4.23–6.04. The
observed rate constants were calculated from the following equation:
kobs ¼ kpH þ kAcH½AcH þ kAC  ½Ac ð2Þ
AcH is the undissociated acetic acid and Ac- is the acetate ion. The total acetate
concentration BT, is:




The observed rate constant was calculated from the pKa of the acetic acid (4.52) and
Eqs. 1 and 2.
kobs ¼ kpH þ BT kAcH½H
þ þ kACKa
½Hþ þ Ka ð5Þ
From the slopes of the plots kobs vs f(BT) for each pH, the buffer catalytic rate
constants were calculated (Table 1). The buffer catalytic effect of phosphate (pH
2.10–3.38, pKa = 2.10 and pH 6.36–7.77, pKa = 6.58), borate (pH 7.95–10.49,
pKa = 8.90) and carbonate (pH = 11.27–11.56, pKa = 10.02) buffers were cal-
culated from the following equations:
kobs ¼ kpH þ BT
kH3PO4 ½Hþ þ kH2PO4 Ka
½Hþ þ Ka ð6Þ
kobs ¼ kpH þ BT
kH2PO4 ½Hþ þ kHPO24 Ka
½Hþ þ Ka ð7Þ
kobs ¼ kpH þ BT
kH3BO4 ½Hþ þ kH2BO3 Ka
½Hþ þ Ka ð8Þ
kobs ¼ kpH þ BT
kHCO3 ½Hþ þ kCO23 Ka
½Hþ þ Ka ð9Þ
From Eqs. 5–9, the kpH and the buffer catalytic rate constants of the phosphate,
acetate, borate and carbonate buffer components were calculated (Table 1a).
The kpH rate constants determined in the buffer solutions and calculated from
Eq. 1 under the conditions of general acid–base catalysis and in hydrochloric acid
(kobs = kpH) were used to calculate the relationship log kpH = f(pH) (Table 2). The
relationship log kpH = f(pH) indicates that in aqueous solutions of doripenem at pH
0.86–11.56 the following reactions occur:
• degradation of the protonated molecules and zwitter ions of doripenem catalyzed
by hydrogen ions (k1 and k2)
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Table 2 Observed rate constants of degradation of doripenem in the pH range 0.82–11.56 at 313 K
pH kobs ± Dkobs (s
-1) pH kobs ± Dkobs (s
-1)
HCl
0.82 (6.65 ± 0.15) 9 10-3 1.38 (7.01 ± 0.47) 9 10-4
1.10 (2.09 ± 0.11) 9 10-3 2.52 (2.52 ± 0.27) 9 10-4
BT (mol/L) kobs ± Dkobs (s
-1) kobs ± Dkobs (s
-1) kobs ± Dkobs (s
-1)
pH 2.10 pH 2.89 pH 3.38
Phosphate buffer, [H3PO4] [KH2PO4]
0.40 (2.84 ± 0.24) 9 10-4 (1.51 ± 0.13) 9 10-4 (9.57 ± 0.46) 9 10-5
0.30 (2.55 ± 0.22) 9 10-3 (1.25 ± 0.09) 9 10-4 (7.02 ± 2.29) 9 10-5
0.20 (1.79 ± 0.28) 9 10-4 (1.03 ± 0.09) 9 10-4 (6.16 ± 0.48) 9 10-5
0.10 (1.38 ± 0.14) 9 10-4 (7.02 ± 0.71) 9 10-4
kpH ± DkpH (8.55 ± 3.08) 9 10
-5 (4.62 ± 1.09) 9 10-5 (2.47 ± 1.51) 9 10-5z
BT (mol/L) kobs ± Dkobs (s
-1) kobs ± Dkobs (s
-1) kobs ± Dkobs (s
-1)
4.23 4.56 4.90
Acetate buffer, [CH3COOH] [CH3CCOO
-]
0.40 (2.75 ± 0.42) 9 10-5 (1.95 ± 0.58) 9 10-5 (1.58 ± 1.71) 9 10-5
0.30 (2.63 ± 0.14) 9 10-5 (1.57 ± 1.08) 9 10-5 (1.22 ± 0.35) 9 10-5
0.20 (2.40 ± 0.14) 9 10-5 (1.08 ± 0.76) 9 10-5 (9.69 ± 5.15) 9 10-6
0.10 (2.01 ± 0.28) 9 10-5 (7.81 ± 0.16) 9 10-6 (5.32 ± 0.91) 9 10-6
kpH ± DkpH (1.73 ± 0.38) 9 10
-5 (3.46 ± 1.54) 9 10-6 (2.27 ± 1.50) 9 10-6z
BT (mol/L) kobs ± Dkobs (s
-1) kobs ± Dkobs (s
-1)
5.47 6.04
0.40 (8.14 ± 2.59) 9 10-6 (3.06 ± 0.98) 9 10-6
0.30 (6.39 ± 1.71) 9 10-6 (2.56 ± 0.18) 9 10-6
0.20 (5.26 ± 0.54) 9 10-6 (2.02 ± 0.26) 9 10-6
0.10 (2.84 ± 0.95) 9 10-6 (1.83 ± 0.20) 9 10-6
kpH ± DkpH (1.40 ± 1.07) 9 10
-6 (1.31 ± 1.07) 9 10-6
BT (mol/L) kobs ± Dkobs (s
-1) BT (mol/L) kobs ± Dkobs (s
-1)




0.40 (1.57 ± 1.41) 9 10-6 0.30 (1.31 ± 0,97) 9 10-5
0.30 (1.23 ± 1.40) 9 10-6 0.25 (1.14 ± 0.98) 9 10-6
0.20 (8.70 ± 1.04) 9 10-7 0.20 (1.01 ± 1.00) 9 10-5
0.10 (6.40 ± 1.39) 9 10-7 0.10 (6.01 ± 12.3) 9 10-6
kpH ± DkpH (2.90 ± 0.35) 9 10
-6 (2.66 ± 0.43) 9 10-6
BT (mol/L) kobs ± Dkobs (s
-1) BT (mol/L) kobs ± Dkobs (s
-1)




0.25 (1.15 ± 0.39) 9 10-5 0.20 (1.30 ± 1.77) 9 10-5
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• spontaneous hydrolysis of zwitter ions of doripenem under the influence of
water (k3)
• degradation of zwitter ions and monoanions of doripenem catalyzed by
hydroxide ions (k4 and k5)
The total rate of the reaction is equal to the sum of the partial reaction rates:
kpH ¼ ðk1  f1 þ k2  f2Þ  aHþ þ k3  f2 þ k4  f2  aOH þ k5  aOH  f3
ð10Þ
where aHþ and aOH are the hydrogen and hydroxide ion activity, f1–f3 are the
fractions of protonated molecules, zwitter ions and monoanions of doripenem. The
Table 2 continued
BT (mol/L) kobs ± Dkobs (s
-1) BT (mol/L) kobs ± Dkobs (s
-1)
pH 7.19 pH 7.77
0.20 (1.03 ± 0.42) 9 10-5 0.15 (1.22 ± 1.47) 9 10-5
0.15 (7.67 ± 1.60) 9 10-6 0.10 (8.54 ± 2.49) 9 10-6
0.10 (6.79 ± 0.64) 9 10-6 0.05 (6.52 ± 2.41) 9 10-6
kpH ± DkpH (3.20 ± 0.85) 9 10
-6 (4.29 ± 1.00) 9 10-6
BT (mol/L) kobs ± Dkobs (s
-1) BT (mol/L) kobs ± Dkobs (s
-1)
pH 7.96 pH 8.57
Borate buffer, [NaBO2] [H3BO3]
0.221 (9.49 ± 1.61) 9 10-4 0.195 (1.61 ± 0.76) 9 10-3
0.166 (7.54 ± 0.39) 9 10-4 0.169 (1.43 ± 0.12) 9 10-3
0.110 (5.46 ± 0.47) 9 10-4 0.147 (1.26 ± 0.20) 9 10-3
0.055 (2.06 ± 0.39) 9 10-4 0.098 (8.09 ± 0.37) 9 10-4
kpH ± DkpH (6.81 ± 0.6) 9 10
-6 (9.88 ± 6.37) 9 10-6
BT (mol/L) kobs ± Dkobs (s
-1) BT (mol/L) kobs ± Dkobs (s
-1)
pH 9.26 pH 10.49
0.162 (3.43 ± 0.27) 9 10-3 0.122 (6.02 ± 0.67) 9 10-3
0.122 (2.89 ± 0.51) 9 10-3 0.099 (4.55 ± 0.45) 9 10-3
0.147 (2.35 ± 0.17) 9 10-3 0.076 (3.48 ± 0.51) 9 10-3
0.098 (8.09 ± 1.02) 9 10-4
kpH ± DkpH (7.62 ± 4.10) 9 10
-5 (7.80 ± 4.47) 9 10-4
BT (mol/L) kobs ± Dkobs (s
-1) BT (mol/L) kobs ± Dkobs (s
-1)
pH 11.27 pH 11.56
Carbonate buffer, [Na2CO3] [NaHCO3]
0.095 (9.73 ± 7.11) 9 10-4 0.095 (5.85 ± 0.41) 9 10-3
0.090 (9.54 ± 6.13) 9 10-4 0.090 (5.79 ± 0.12) 9 10-3
0.075 (8.72 ± 0.86) 9 10-4 0.075 (5.61 ± 0.17) 9 10-3
0.060 (8.07 ± 5.11) 9 10-4 0.060 (5.45 ± 0.72) 9 10-3
kpH ± DkpH (3.92 ± 0.41) 9 10
-3 (4.76 ± 0.18) 9 10-3
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f1–f3 values were calculated by using the values of pKa of doripenem that were 3.5
and 7.3 at 313 K.
The partial reaction rates (k1 and k2) were calculated by using the values of kpH
from the pH range 1.10–4.56. In this pH range f1 ? f2 = 1. The plot kpH=aHþ ¼
fðf2Þ is linear. The partial reaction rates k1 (1.66 9 10-2 L mol-1 s1) and k2
(1.31 9 10-1 L mol-1 s-1) are equal to the values of kpH=aHþ for f2 = 0 and
f2 = 1, respectively. The partial reaction rates k4 and k5, were calculated by using
the values of kpH from the pH range 7.19–11.56. In this pH range, f2 ? f3 = 1. The
kpH=aOH ¼ fðf2Þ plot is linear. The reaction rate k4 (11.64 L mol-1 s-1) is equal to
the value of kpH=aOH for f2 = 1, while k5 (8.33 9 10
-1 L mol-1 s-1) is equal to
the value of kpH=aOH for f2 = 0.
The mean value of the partial reaction rate (k3 = 7.87 9 10
-7 s-1)
was calculated from Eq. 10 by using the kpH values of kpH from the pH range
4.90–6.04:
k0pH ¼ ½kpH  ðk1  aHþ  f1 þ k2  aHþ  f2 þ k4  f2  aOH þ k5  aOH
 f3Þ=f2
The correct choice of Eq. 10 was verified by comparing the calculated theoretical
profile of log kpH = f(pH) and the experimental results (Fig. 4).
The pH-rate profiles of imipenem, ertapenem and doripenem demonstrate that
they are the most stable in the pH range 6–7. This is the pH range where the
spontaneous hydrolysis of the neutral and ionic molecules of carbapenem occurs.
The influence of the catalytic effect of the components of phosphate and acetate
buffers on the degradation of these carbapenems is similar. The components of a
borate buffer have the greatest catalytic effect on the degradation of imipenem and
ertapenem. A comparison of the values of the catalytic rate constants of a carbonate
buffer shows that its components have a slight catalytic effect on the degradation of
imipenem and do not catalyze the degradation of ertapenem (Table 1b). Therefore,
the components of a carbonate buffer can be used in preparations of carbapenems as
excipients, e.g. hydrocarbonate sodium in INVANZ and TIENAM and carbonate
sodium in MERREM, MERONEM. Doripenem is susceptible to degradation under
the influence of the components of common buffers. For that reason, no excipients
are present in DORIBAXTM.
Conclusions
Doripenem is susceptible to degradation catalyzed by the components of common
buffers. Therefore DORIBAXTM contains doripenem without any excipients. The
specific acid–base catalysis of doripenem involves: (a) degradation of the
protonated molecules and zwitter ions of doripenem catalyzed by hydrogen ions,
(b) spontaneous degradation of zwitter ions under the influence of water, (c)
degradation of zwitter ions and monoanions catalyzed by hydroxide ions.
Doripenem demonstrates the greatest stability at approximately pH 6.0.
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